Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05285553 · ClinicalTrials.gov registry record · NA

MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms

A NA study of Myopia, sponsored by CooperVision.

Recruiting
Registry status
NA
Development phase
900
Enrollment target
20
Study locations

NCT05285553 is a NA study of Myopia that is actively recruiting participants, run by CooperVision. The registered enrollment target is 900 participants, above the 258-participant average among 90 other Myopia trials with a reported enrollment target (249% higher). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05285553, a NA study of Myopia, is actively recruiting participants, sponsored by CooperVision.

RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this post-approval study is to confirm the effectiveness of the MiSight 1 Day lens in clinical practices within the US and to assess the stability of the myopia reduction over one-year post-treatment.

Conditions Studied

Myopia

Interventions

  • DEVICE MiSight 1 Day
  • DEVICE Proclear 1 day

Study Locations (20)

Illinois

  • SoLo Eye Care & Eyewear Gallery - Chicago
  • Illinois College of Optometry - Chicago
  • Chicago College of Optometry - Downers Grove
  • Carillon Vision Care - Glenview
  • Brain Vision Institute - Schaumburg

California

  • Marshall B. Ketchum University Southern California College of Optometry - Fullerton
  • Vision Solutions Optometry Inc - La Mesa
  • Paje Optometric - Santa Ana

Florida

  • Coan Eye Care and Optical Boutique - Ocoee
  • West Broward Eyecare Associates - Tamarac
  • Bright Eyes Family Vision Care - Tampa

Ohio

  • Athens Eye Care - Athens
  • Ohio State University - Columbus
  • ProCare Vision Center, Inc. - Granville

Alabama

  • University of Alabama School of Optometry - Birmingham

Indiana

  • Clinical Optics Research Lab at IU School of Optometry - Bloomington

Kansas

  • Kannarr Eye Care - Pittsburg

Massachusetts

  • New England College of Optometry - Boston

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2022-06-25
Est. Completion 2027-06-30
Phase NA

Sponsor

CooperVision

64 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05285553

The ClinicalTrials.gov registry entry for NCT05285553 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 258-participant average among 90 other Myopia trials with a reported enrollment target (249% higher). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which MiSight 1 Day is the first listed.

NCT05285553 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Illinois, California, Florida.

Frequently Asked Questions

What is clinical trial NCT05285553 about?

NCT05285553 is a clinical study titled "MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms". The purpose of this post-approval study is to confirm the effectiveness of the MiSight 1 Day lens in clinical practices within the US and to assess the stability of the myopia reduction over one-year post-treatment.

What is the current status of trial NCT05285553?

This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2022-06-25. Estimated completion is 2027-06-30.

What conditions does trial NCT05285553 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT05285553?

The interventions under investigation include: MiSight 1 Day (DEVICE), Proclear 1 day (DEVICE).

Who is sponsoring clinical trial NCT05285553?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05285553 being conducted?

This trial has 20 study locations across Alabama, California, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myopia

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.